Skip to content

13F-HR filed by RHO CAPITAL PARTNERS INC

RHO CAPITAL PARTNERS INC filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-12, with 7 holding rows worth $179,387,000.

Accession
0001420506-21-001566
Filed
2021-11-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2021

A holdings report, 7 entries on the cover page, a total value of $179,387,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $179,387,000 with VALUE read as thousands by filing date, 13F file number 028-05883. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CHARGEPOINT HLDGS INC15961R105COM CL A4,053,257$81,025,000thousands by filing date
NGM BIOPHARMACEUTICALS INC62921N105COM3,766,666$79,175,000thousands by filing date
LIVEXLIVE MEDIA INC53839L208COM NEW3,724,137$11,135,000thousands by filing date
Mersana Therapeutics Inc59045L106Common Stock796,458$7,511,000thousands by filing date
SENSEONICS HLDGS INC81727U105COM159,601$541,000thousands by filing date
ON24 INC68339B104COM0$0thousands by filing dateValue filed as zero, left out of ratios.Amount filed as zero, left out of ratios.
CARA THERAPEUTICS INC140755109COM0$0thousands by filing dateValue filed as zero, left out of ratios.Amount filed as zero, left out of ratios.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-21-001566this filing2021-11-12acceptance time not in the bulk data set